Pediatric patients with pheochromocytoma and paraganglioma should have routine preoperative genetic testing for common susceptibility genes in addition to imaging to detect extra-adrenal and metastatic tumors
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Pheochromocytoma and ParagangliomaHematology/Oncology Clinics of North America, 2016
- Pheochromocytomas in Multiple Endocrine Neoplasia Type 22015
- Localization and prediction of malignant potential in recurrent pheochromocytoma/paraganglioma (PCC/PGL) using 18F-FDG PET/CTActa Radiologica, 2014
- Genetics of pheochromocytoma and paraganglioma in Spanish pediatric patientsEndocrine-Related Cancer, 2013
- MAX Mutations Cause Hereditary and Sporadic Pheochromocytoma and ParagangliomaClinical Cancer Research, 2012
- Metastatic Pheochromocytoma/Paraganglioma Related to Primary Tumor Development in Childhood or Adolescence: Significant Link to SDHB MutationsJournal of Clinical Oncology, 2011
- Pheochromocytoma associated with neurofibromatosis type 1: concepts and current trendsWorld Journal of Surgical Oncology, 2010
- Characteristics of Pheochromocytoma in a 4‐ to 20‐Year‐Old PopulationAnnals of the New York Academy of Sciences, 2006
- Clinical and Genetic Characteristics of Patients with Neurofibromatosis Type 1 and PheochromocytomaNew England Journal of Medicine, 2006
- Pheochromocytoma Surgery: Epidemiologic Peculiarities in ChildrenWorld Journal of Surgery, 2004